<DOC>
	<DOC>NCT02419508</DOC>
	<brief_summary>The purpose of this study is to evaluate the additive intraocular pressure (IOP) lowering effect of brinzolamide 1%/brimonidine 0.2% (dosed twice per day (BID)) when added to a PGA in patients with open-angle glaucoma or ocular hypertension.</brief_summary>
	<brief_title>SIMBRINZA速 Suspension BID as an Adjunctive to Prostaglandin Analogue (PGA)</brief_title>
	<detailed_description>This study consists of 2 sequential phases: Screening/Eligibility Phase, which includes a Run-in/Washout (Phase I), and Masked Treatment Phase (Phase II). At the Screening Visit, subjects will be assigned into one of 3 PGA therapy groups for the duration of the study. Subjects previously prescribed TRAVATAN速, XALATAN速, or LUMIGAN速 monotherapy with uncontrolled IOP will not need a run-in period with PGA.</detailed_description>
	<mesh_term>Glaucoma, Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<mesh_term>Brimonidine Tartrate</mesh_term>
	<mesh_term>Brinzolamide</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Diagnosis of either openangle glaucoma or ocular hypertension; Must sign an informed consent form; Willing and able to attend all study visits; Other protocolspecified inclusion criteria may apply. Women of childbearing potential who are pregnant, breastfeeding, intend to become pregnant during the study, or not using adequate birth control methods to prevent pregnancy throughout the study; Any form of glaucoma other than openangle glaucoma or ocular hypertension; Ocular disease, trauma, infection, inflammation, pathology, or surgery as specified in the protocol; Any other conditions including severe illness which would make the subject, in the opinion of the Investigator, unsuitable for the study; Other protocolspecified exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>